FDA rejects NRx Pharmaceuticals’ emergency use request for its experimental Covid-19 treatment


The Radnor company repeated that it is now focusing on its new drug candidate for bipolar depression.

Previous Fee sharing, telehealth raise Florida medical marijuana questions
Next BrightSpring adds former Humana exec to C-suite